Anti-Tumour Effect Of A Chitosan Delivery System For Doxorubicin

被引:1
作者
Tan, Mei Lin [1 ]
Choong, Peter F. M. [1 ]
Dass, Crispin R. [1 ]
机构
[1] St Vincents Hosp Melbourne, Dept Orthopaed, Melbourne, Vic, Australia
来源
FUNCTIONALIZED AND SENSING MATERIALS | 2010年 / 93-94卷
关键词
chitosan; delivery; complex; doxorubicin; cancer; HUMAN OSTEOSARCOMA; NANOPARTICLES; CANCER; MODEL; BONE;
D O I
10.4028/www.scientific.net/AMR.93-94.703
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were formed. Multiple optimisation steps produced DMPs which caused tumour cell death. Treatment of mice bearing tumours with DMP decreased tumour growth and spread, with no visible side-effects. There are plans to evaluate this delivery vehicle more closely towards clinical development and testing.
引用
收藏
页码:703 / 706
页数:4
相关论文
共 8 条
[1]  
BERLIN O, 1993, CANCER RES, V53, P4890
[2]   A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma [J].
Dass, Crispin R. ;
Ek, Eugene T. ;
Contreras, Karla G. ;
Choong, Peter F. .
CLINICAL & EXPERIMENTAL METASTASIS, 2006, 23 (7-8) :367-380
[3]   Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review [J].
Kremer, LCM ;
van Dalen, EC ;
Offringa, M ;
Voûte, PA .
ANNALS OF ONCOLOGY, 2002, 13 (04) :503-512
[4]   Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma [J].
Longhi, Alessandra ;
Ferrari, Stefano ;
Bacci, Gaetano ;
Specchia, Salvatore .
ANTI-CANCER DRUGS, 2007, 18 (06) :737-744
[5]   Primary bone osteosarcoma in the pediatric age: State of the art [J].
Longhi, Alessandra ;
Errani, Costantino ;
De Paolis, Massimiliano ;
Mercuri, Mario ;
Bacci, Gaetano .
CANCER TREATMENT REVIEWS, 2006, 32 (06) :423-436
[6]   Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier [J].
Mitra, S ;
Gaur, U ;
Ghosh, PC ;
Maitra, AN .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :317-323
[7]   Cancer, chitosan nanoparticles and catalytic nucleic acids [J].
Tan, Mei Lin ;
Choon, Peter F. M. ;
Dass, Crispin R. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (01) :3-12
[8]   Review: doxorubicin delivery systems based on chitosan for cancer therapy [J].
Tan, Mei Lin ;
Choong, Peter F. M. ;
Dass, Crispin R. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (02) :131-142